Fig. 1From: Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patientsSurvival analysis of elderly breast cancer patients according to CD8+ T-cell responses to Her-2peptides in vitro. Survival analysis of elderly patients (n = 38) grouped according to CD8+ T-cell responses to Her-2 (CD8 response), CD4+ and CD8+ T-cell responses (CD4 & CD8response) and CD4+ T-cell responses to Her-2 (CD4 response)Back to article page